Kestra Advisory Services’s ProQR Therapeutics PRQR Stock Holding History

Kestra Advisory Services’s Portfolio PRQR Stock Details PRQR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$21.3K	–	4566
2025 Q3	$21.3K	Hold	10,000	–	–	﹤0.01%	2881
2025 Q2	$20.4K	Hold	10,000	–	–	﹤0.01%	2799
2025 Q1	$13.3K	Hold	10,000	–	–	﹤0.01%	2702
2024 Q4	$26.5K	Hold	10,000	–	–	﹤0.01%	2632
2024 Q3	$18.2K	Hold	10,000	–	–	﹤0.01%	2534
2024 Q2	$16.6K	Hold	10,000	–	–	﹤0.01%	2593
2024 Q1	$22.9K	Hold	10,000	–	–	﹤0.01%	2429
2023 Q4	$19.8K	Hold	10,000	–	–	﹤0.01%	2247
2023 Q3	$13K	Hold	10,000	–	–	﹤0.01%	2093
2023 Q2	$16.2K	Hold	10,000	–	–	﹤0.01%	2085
2023 Q1	$21.3K	Hold	10,000	–	–	﹤0.01%	2021
2022 Q4	$37K	Hold	10,000	–	–	﹤0.01%	2193
2022 Q3	$7K	Hold	10,000	–	–	﹤0.01%	2088
2022 Q2	$8K	Sell	10,000 -500	-5%	-$373	﹤0.01%	2111
2022 Q1	$10K	Hold	10,500	–	–	﹤0.01%	1989
2021 Q4	$84K	Hold	10,500	–	–	﹤0.01%	1954
2021 Q3	$88K	Buy	10,500 +500	+5%	+$3.27K	﹤0.01%	2065
2021 Q2	$67K	Hold	10,000	–	–	﹤0.01%	1966
2021 Q1	$66K	Hold	10,000	–	–	﹤0.01%	1819
2020 Q4	$42K	Buy	+10,000	New	+$42.2K	﹤0.01%	1821

Other funds holding PRQR

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PFM

Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Kestra Advisory Services's PRQR Position: Q4 2025 in Review

Kestra Advisory Services sold out of ProQR Therapeutics (PRQR) in Q4 2025, closing a stake of 10,000 shares — an estimated $21.3K sold.

Kestra Advisory Services first reported a position in PRQR in Q4 2020 and held it in 20 quarters. The position peaked at $88K in Q3 2021. 65 funds tracked by Wall St. Rank hold PRQR as of Q4 2025.

Kestra Advisory Services reported no remaining ProQR Therapeutics position as of Q4 2025 after selling out during the quarter.
Kestra Advisory Services sold 10,000 ProQR Therapeutics shares in Q4 2025, an estimated $21.3K.
Kestra Advisory Services first reported a position in ProQR Therapeutics in Q4 2020 and held it in 20 quarters.
Kestra Advisory Services's ProQR Therapeutics position peaked at $88K in Q3 2021.
65 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q4 2025.

Based on Kestra Advisory Services's 13F filing for Q4 2025, filed 13 Feb 2026.